Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,303 total articles
ABM Industries Incorporated announced the release of its fiscal second quarter 2026 financial results on June 5, 2026, prior to market opening. The company will host a conference call and webcast for investors to discuss the results, with a replay available for 90 days. ABM is a leading provider of integrated facility solutions serving diverse sect…
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company, received a notification from Nasdaq regarding non-compliance with listing rules due to the late filing of its Form 10-Q for the quarterly period ending March 31, 2026. The company has until July 20, 2026, to submit a plan to regain compliance and is currently working to complet…
BitFuFu Inc., a leading Bitcoin mining company listed on NASDAQ under ticker FUFU, announced it will release its unaudited financial results for the first quarter of 2026 on May 29, 2026, before the U.S. market opens. The management will hold an earnings conference call the same day to discuss the results. The company specializes in Bitcoin mining …
Repligen Corporation, a leader in bioprocessing technologies, announced its participation in the William Blair 46th Annual Growth Stock Conference with a presentation by its CEO on June 3rd. The presentation will provide a company overview and highlight its focus on innovative bioprocessing technologies supporting biological drug manufacturing.
BriaCell Therapeutics announced positive clinical data from its Phase 2 and ongoing Phase 3 studies evaluating Bria-IMT immunotherapy in heavily pre-treated metastatic breast cancer patients. The data highlighted median overall survival improvements, preserved quality of life, and biomarker analyses supporting predictors of response. No safety conc…
Assembly Biosciences, a Nasdaq-listed biotechnology company, announced the pricing of a $100 million offering of common stock and pre-funded warrants. The proceeds are intended to support the clinical development of its pipeline candidates targeting serious viral and liver diseases. The offering attracted participation from new and existing investo…
Regeneron Pharmaceuticals announced that the European Medicines Agency (EMA) has accepted for review under Accelerated Assessment the Marketing Authorization Application for Otarmeni™ (lunsotogene parvec), a gene therapy for biallelic OTOF variant-associated hearing loss. Otarmeni is already approved in the U.S. and this approval could mark the fir…
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery and advanced radiation therapy services, announced its 2026 Annual Shareholder Meeting to be held virtually on June 24, 2026. Shareholders of record on April 27, 2026, are eligible to participate and vote. The company continues to focus on expanding inte…
Assembly Biosciences, Inc. announced the expansion of its clinical development program for ABI-6250, an oral entry inhibitor originally targeted for chronic hepatitis delta virus (HDV) infection, to include primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). A Phase 2 study focusing on these cholestatic liver diseases is exp…
Chagee Holdings Limited, a premium tea drinks brand listed on NASDAQ under the ticker CHA, announced it will report its first quarter 2026 financial results on May 28, 2026. The company will hold a conference call to discuss the results and engage with investors, continuing its commitment to transparency and communication.
Concorde International Group Ltd. (NASDAQ: YOOV), a technology-enabled security solutions provider, was featured in the official World FM Day 2026 video by the Singapore International Facility Management Association. The company’s proprietary operational security model, protected by patents in 29 jurisdictions, has been recognized for driving indus…
Destination XL Group, Inc. announced it is reviewing an unsolicited $0.82 per share cash tender offer from Zodiac Partners II, LLC while balancing its fiduciary duties and an existing merger agreement with FBB Holdings I, Inc. The Board is consulting financial and legal advisors to decide on a recommendation for shareholders, who are advised to tak…
AC Immune SA reported new Phase 1 data demonstrating that its TDP-43 PET tracer ACI-19626 has higher uptake in the brains of patients with amyotrophic lateral sclerosis (ALS), indicating its potential to detect TDP-43 pathology. This early detection capability may enable precision medicine approaches for neurodegenerative diseases such as ALS and f…
Rocket Lab Corporation announced the successful deployment of the ninth satellite for Synspective using its Electron rocket, reinforcing its position as the premier small satellite launch provider. The mission advances Synspective's synthetic aperture radar Earth observation constellation and demonstrates Rocket Lab's commitment to tailored launch …
LyondellBasell announced a quarterly dividend of $0.69 per share payable on June 8, 2026, with an ex-dividend date of June 1, 2026. The company highlights its leadership in the global chemical industry and focus on sustainable innovations.
FTAI Aviation Ltd., a US-listed company (NASDAQ: FTAI), announced the successful pricing of its inaugural asset-backed securitization (ABS) under its Strategic Capital vehicle, raising $612 million through the issuance of two classes of investment grade notes backed by a portfolio of 48 narrowbody aircraft leased to 23 global airlines. The transact…
Yimutian Inc. announced the full deployment of its WolaiCai AI Agent across all platforms, achieving over 200 million daily token consumption and generating approximately US$3,000 in daily revenue from agricultural AI products. The AI agent improves transaction efficiency between buyers and sellers in agricultural trading by automating procurement …
Lixiang Education Holding Co., Ltd. announced successful compliance with Nasdaq's minimum bid price requirement following a 1-for-10 reverse stock split, resolving previous non-compliance issues and securing continued listing on the exchange.
NIO Inc., a leading global smart electric vehicle manufacturer, announced its Annual General Meeting to be held on June 24, 2026, in Shanghai. The company also released its annual report (Form 20-F) for the fiscal year ended December 31, 2025, filed with the U.S. SEC. NIO's board supports the proposed resolutions to be voted on at the AGM. Voting i…
BioNTech SE announced encouraging clinical trial updates from its late-stage oncology pipeline at the 2026 ASCO Annual Meeting. Data highlights include positive anti-tumor activity of pumitamig in first-line non-small cell lung cancer and gotistobart showing durable activity in platinum-resistant ovarian cancer. The company continues to advance ove…
NervGen Pharma Corp., a clinical-stage biopharmaceutical company focused on neuroreparative therapies, announced an underwritten public offering of 24 million common shares and accompanying warrants priced at $2.50 each, raising approximately $60 million before expenses. The proceeds will be used to advance their lead candidate NVG-291 through clin…
Yimutian Inc., a China-based agricultural digital services company listed on Nasdaq, has submitted a hearing request to the Nasdaq Hering Panel after receiving a defiency notification related to minimum market value listing standards. The submission halts any delisting process pending the hearing outcome. Yimutian is executing strategic initiatives…
Medline Inc. has priced an upsized secondary offering of approximately 72.55 million shares of its Class A common stock by selling stockholders affiliated with Blackstone, Hellman & Friedman, and Abu Dhabi Investment Authority at $37 per share. Medline itself is not selling shares nor receiving proceeds from the offering. The offering is expected t…
All In FutureTech Alliance Inc. (Nasdaq: AGAE) announced the filing of its 2025 Annual Report on Form 10-K, addressing previous Nasdaq compliance issues regarding late filings. With major litigation disputes resolved, the company aims to continue its strategic transformation from experiential entertainment to an AI-powered digital infrastructure pl…
Liminatus Pharma, a biopharmaceutical company focused on oncology and serious diseases therapies, received a Nasdaq delisting notification as it failed to meet the minimum market value of listed securities and publicly held shares criteria. The company intends to appeal the decision but faces suspension of its securities trading and removal from Na…
